FinBoss.io
CSEN
  • Crypto prices
  • Liquidation War
  • Crypto tools
  • Bitcoin on-chain
  • US macro
  • US stocks
    • Largest US stocks
    • Stock screener
    • Earnings calendar
    • Insider trading
    • Market heatmap
  • Markets
  • Tools
  • Guides
  • FinBot
FinBoss.io
Crypto prices
Liquidation War
Crypto tools
Altcoin Season Index
Big players (on-chain)
Bitcoin halving countdown
Bear market radar
Bitcoin on-chain
Hashrate
Mining difficulty
Mining pools
Mempool and fees
On-chain activity
MVRV and NUPL
SOPR
Holders
Supply in profit
Rainbow Chart
Fair value
Pi Cycle Top
US macro
FedWatch
Interest rates
Treasury yields
Inflation
Liquidity and Bitcoin
Business cycle
US stocks
Largest US stocks
Stock screener
Earnings calendar
Insider trading
Market heatmap
Markets
Stock indices
Commodities
Forex rates
Bear market radar
Famous investors' portfolios
Tools
Dashboards
Investor dashboardTrader dashboardBeginner dashboard
Calculators
Compound interestDCA calculatorDrawdown recovery
Compare
BrokersCrypto exchanges
Přehled sekce Tools →
Guides
FinBot
CSEN
Home
Stocks
Sotera Health Co
SH

Sotera Health Co

SHCNASDAQ

Stock · Data from SEC EDGAR 13F · Held by 10 of 87 tracked investors

$18.49
▲ 0.54%
Famous investorshold 10buying 0selling 0
Price (USD)
$18.49
Market cap
$5.3B
P/E ratio
32.4
Tracked investors holding
10 of 87
Next earnings
3 Nov 2026

Sotera Health Co at a glance

An overview of the financial statements, in plain language. Switch to the advanced view for charts.

FinBoss score
61out of 100
  • Valuation43
  • Growth58
  • Profitability82
  • Quality83
  • Debt25
  • Stability76
In its favour
  • ✓It earns 28 USD a year on every 100 USD of invested capital (ROE).
  • ✓The analysts' average target is 22% above the price.
What to watch
  • !Net debt is high: at the current free cash flow it would take 12.4 years to repay.

The score describes the quality and the past of the company based on its statements (the FinBoss model, indicative). A high score is not a buy signal and a low one is not a sell signal. Data source: Yahoo Finance, prices and statements in USD.

Is the stock expensive?

Fairly expensive

For 1 USD of annual earnings you pay 32.4 USD. Based on next year's estimates 17.2 USD.

P/E
32.4×
P/S
4.3×
EV/EBITDA
12.4×

Is the company growing?

Growing slowly
22
23
24
25

Revenue over 3 years grew 5.1% a year. Last year 9.2%.

Does it make money?

Good

Revenue and net profit (USD B)

Margins (% of revenue)

Free cash flow and capex (USD B)

Cash and debt (USD B)

Earnings per share (EPS, USD)

Latest quarters (USD B)

Chart SHC

Insider purchases

last 90 days, SEC Form 4
Loading insider trades…

Which investors hold this stock

10
SF
Scott Ferguson
Sachem Head Capital
5.73%$276,190,000▲ +33.6%
DE
David Einhorn
Greenlight Capital
0.28%$5,677,944unchanged
JG
Joel Greenblatt
Gotham Asset Management
0.09%$39,164,612▲ +92.4%
CA
Cliff Asness
AQR Capital Management
0.06%$186,401,345▲ +59.7%
LB
Louis Bacon
Moore Capital Management
0.06%$3,797,542▼ -15.2%
PT
Paul Tudor Jones
Tudor Investment Corp
0.02%$17,485,880▲ +16.6%
IE
Israel Englander
Millennium Management
0.01%$34,303,366▲ +506.2%
Ns
Norský státní fond
Norges Bank
0.01%$62,346,857New position
Šn
Švýcarská národní banka
Swiss National Bank
0.01%$9,902,725▲ +32.8%
RD
Ray Dalio
Bridgewater Associates
0%$341,528▼ -97.2%

Frequently asked questions

How much is Sotera Health Co (SHC) stock?

Sotera Health Co shares trade at $18.49, +0.54% over the last trading day. The price is delayed.

What is the market cap of Sotera Health Co?

The market cap of Sotera Health Co is about $5.3B and its price-to-earnings ratio (P/E) is 32.4.

Which big investors hold Sotera Health Co?

According to the latest 13F filings, 10 of 87 tracked investors hold Sotera Health Co, for example Scott Ferguson, David Einhorn, Joel Greenblatt.

When will Sotera Health Co report its next results?

The next earnings report of Sotera Health Co is expected on 3 Nov 2026.

Source: SEC EDGAR 13F-HR (quarterly filings). The data is indicative and is not investment advice.

© 2026 FinBoss.io. All rights reserved.

How we make moneyTerms of usePrivacy policyCookie policy

Disclaimer: the information on this site is for general information only and is not investment or financial advice. Investing involves risk, and cryptocurrencies are especially volatile. Past performance does not guarantee future results. Some links are affiliate links and are marked as ads.

  • Cost of sales 45
  • Research 0.0
  • Operations and selling 24.4
  • Taxes and other 24.4
  • Net profit 6.7

Out of 100 USD of revenue, 6.7 USD is left as net profit.

Is it financially healthy?

Watch the debt
Cash
357M USD
Debt
2.3B USD
Free CF
154M USD

It could repay its net debt from free cash flow in 12.4 years.

Does it pay a dividend?

No dividend

The company pays no dividend. It reinvests the money or holds it.

What do analysts expect?

Buy
Average target
22.61 USD
Vs price
+22%

9 analysts. Their opinion is not a recommendation by FinBoss.io.

Which big investors hold it?

10 of 87

Among the tracked investors, Scott Ferguson, David Einhorn, Joel Greenblatt and others hold the stock according to 13F filings.

Ratios

P/E
32.4×
Forward P/E
17.2×
P/B
7.9×
P/S
4.3×
PEG
1.31
EV/EBITDA
12.4×
Gross margin
55.0%
Operating margin
38.0%
Net margin
13.4%
ROE
27.8%
ROA
8.6%
Debt / equity
3.4×
Current ratio
2.8×
Revenue growth
9.2%
Earnings growth
569.5%
Beta
1.86
Dividend
0.00%
Payout ratio
0%